| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.22 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |